{"AllianceGenome": "6570", "HGNC": "6570", "MIM": "601879", "_id": "3965", "_version": 3, "accession": {"genomic": ["AB040130.2", "AC015688.11", "AJ288083.1", "AJ288084.1", "AJ288087.1", "AJ288088.1", "AJ288089.1", "CH471159.1", "CP068261.2", "NC_000017.11", "NC_060941.1"], "protein": ["AAI05943.1", "AAI05945.1", "AAI10341.1", "BAA22166.1", "BAA31542.1", "BAB83623.1", "BAB83624.1", "BAB83625.1", "BAD96952.1", "BAF76327.1", "BAF76328.1", "BAG54277.1", "BAG58799.1", "BAG63109.1", "CAA88922.1", "CAB93851.1", "EAW51037.1", "EAW51038.1", "EAW51039.1", "EAW51040.1", "EAW51041.1", "EAW51042.1", "EAW51043.1", "EAW51044.1", "EAW51045.1", "NP_001317092.1", "NP_002299.2", "NP_033665.1", "O00182.2", "XP_006721955.1", "XP_006721956.1", "XP_006721958.1", "XP_011523098.1", "XP_054172020.1", "XP_054172021.1", "XP_054172022.1", "XP_054172023.1"], "rna": ["AB003517.1", "AB005894.1", "AB006782.1", "AB008492.1", "AK126017.1", "AK223232.1", "AK296031.1", "AK301624.1", "BC034392.1", "BC105942.1", "BC105944.1", "BC110340.1", "BX400388.2", "DA999005.1", "NM_001330163.2", "NM_002308.4", "NM_009587.3", "NR_024043.2", "XM_006721892.4", "XM_006721893.4", "XM_006721895.5", "XM_011524796.3", "XM_054316045.1", "XM_054316046.1", "XM_054316047.1", "XM_054316048.1", "Z49107.1"], "translation": [{"protein": "XP_006721956.1", "rna": "XM_006721893.4"}, {"protein": "XP_054172023.1", "rna": "XM_054316048.1"}, {"protein": "XP_054172022.1", "rna": "XM_054316047.1"}, {"protein": "AAI10341.1", "rna": "BC110340.1"}, {"protein": "BAF76327.1", "rna": "AB003517.1"}, {"protein": "CAA88922.1", "rna": "Z49107.1"}, {"protein": "AAI05943.1", "rna": "BC105942.1"}, {"protein": "NP_001317092.1", "rna": "NM_001330163.2"}, {"protein": "BAG54277.1", "rna": "AK126017.1"}, {"protein": "BAG58799.1", "rna": "AK296031.1"}, {"protein": "BAD96952.1", "rna": "AK223232.1"}, {"protein": "XP_054172020.1", "rna": "XM_054316045.1"}, {"protein": "XP_006721958.1", "rna": "XM_006721895.5"}, {"protein": "NP_002299.2", "rna": "NM_002308.4"}, {"protein": "BAA22166.1", "rna": "AB006782.1"}, {"protein": "BAA31542.1", "rna": "AB005894.1"}, {"protein": "NP_033665.1", "rna": "NM_009587.3"}, {"protein": "AAI05945.1", "rna": "BC105944.1"}, {"protein": "XP_054172021.1", "rna": "XM_054316046.1"}, {"protein": "BAF76328.1", "rna": "AB008492.1"}, {"protein": "XP_011523098.1", "rna": "XM_011524796.3"}, {"protein": "BAG63109.1", "rna": "AK301624.1"}, {"protein": "XP_006721955.1", "rna": "XM_006721892.4"}]}, "alias": ["HUAT", "LGALS9A"], "ensembl": {"gene": "ENSG00000168961", "protein": ["ENSP00000306228", "ENSP00000318214", "ENSP00000378856", "ENSP00000462359", "ENSP00000462382", "ENSP00000462668", "ENSP00000463125", "ENSP00000464581", "ENSP00000467505"], "transcript": ["ENST00000302228", "ENST00000313648", "ENST00000395473", "ENST00000448970", "ENST00000467111", "ENST00000481514", "ENST00000486774", "ENST00000577392", "ENST00000578944", "ENST00000579402", "ENST00000579930", "ENST00000580779", "ENST00000581710", "ENST00000583671", "ENST00000584386", "ENST00000584661"], "translation": [{"protein": "ENSP00000306228", "rna": "ENST00000302228"}, {"protein": "ENSP00000318214", "rna": "ENST00000313648"}, {"protein": "ENSP00000463125", "rna": "ENST00000580779"}, {"protein": "ENSP00000378856", "rna": "ENST00000395473"}, {"protein": "ENSP00000462359", "rna": "ENST00000577392"}, {"protein": "ENSP00000467505", "rna": "ENST00000584661"}, {"protein": "ENSP00000462668", "rna": "ENST00000467111"}, {"protein": "ENSP00000462382", "rna": "ENST00000581710"}, {"protein": "ENSP00000464581", "rna": "ENST00000578944"}], "type_of_gene": "protein_coding"}, "entrezgene": "3965", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 14.6467828543, "exp_mis": 135.010591465, "exp_syn": 62.9156229794, "lof_z": 1.97923474658447, "mis_z": 2.1052061453604, "mu_lof": 9.59083538539e-07, "mu_mis": 1.22432519242e-05, "mu_syn": 5.50635471828e-06, "n_lof": 7.0, "n_mis": 85.0, "n_syn": 45.0, "p_li": 0.00139053962852711, "p_null": 0.0344607333224317, "p_rec": 0.964148727049041, "syn_z": 1.40023867060976}, "bp": 1068, "cds_end": 25976008, "cds_start": 25958291, "n_exons": 11, "nonpsych": {"exp_lof": 13.0435511204, "exp_mis": 121.98441638, "exp_syn": 56.7315139502, "lof_z": 1.64341128391722, "mis_z": 1.96300044812074, "mu_lof": 9.59083538539e-07, "mu_mis": 1.22432519242e-05, "mu_syn": 5.50635471828e-06, "n_lof": 7.0, "n_mis": 79.0, "n_syn": 43.0, "p_li": 0.000835276533643703, "p_null": 0.0781466271660378, "p_rec": 0.921018096300318, "syn_z": 1.14780902759572}, "nontcga": {"exp_lof": 13.4542591091, "exp_mis": 124.188971495, "exp_syn": 57.8615986606, "lof_z": 2.27366731968701, "mis_z": 2.06493606403216, "mu_lof": 9.59083538539e-07, "mu_mis": 1.22432519242e-05, "mu_syn": 5.50635471828e-06, "n_lof": 5.0, "n_mis": 78.0, "n_syn": 42.0, "p_li": 0.0250329849124007, "p_null": 0.0131601064378151, "p_rec": 0.961806908649784, "syn_z": 1.32030436159328}, "transcript": "ENST00000395473.2"}, "exons": [{"cdsend": 27648914, "cdsstart": 27631265, "chr": "17", "position": [[27631187, 27631304], [27638262, 27638354], [27640571, 27640773], [27642237, 27642348], [27645313, 27645349], [27645860, 27645911], [27646546, 27646588], [27647029, 27647118], [27648835, 27649560]], "strand": 1, "transcript": "NM_001330163", "txend": 27649560, "txstart": 27631187}, {"cdsend": 27648982, "cdsstart": 27631265, "chr": "17", "position": [[27631187, 27631304], [27638262, 27638354], [27640571, 27640773], [27642237, 27642348], [27645313, 27645349], [27645860, 27645911], [27646546, 27646588], [27647029, 27647118], [27647269, 27647432], [27648835, 27649560]], "strand": 1, "transcript": "NM_002308", "txend": 27649560, "txstart": 27631187}, {"cdsend": 27648982, "cdsstart": 27631265, "chr": "17", "position": [[27631187, 27631304], [27638262, 27638354], [27640571, 27640773], [27642237, 27642348], [27643524, 27643620], [27645313, 27645349], [27645860, 27645911], [27646546, 27646588], [27647029, 27647118], [27647269, 27647432], [27648835, 27649560]], "strand": 1, "transcript": "NM_009587", "txend": 27649560, "txstart": 27631187}, {"cdsend": 27649560, "cdsstart": 27649560, "chr": "17", "position": [[27631187, 27631304], [27638262, 27638354], [27640642, 27640773], [27642237, 27642348], [27645313, 27645349], [27645860, 27645911], [27646546, 27646588], [27647029, 27647118], [27647269, 27647432], [27648835, 27649560]], "strand": 1, "transcript": "NR_024043", "txend": 27649560, "txstart": 27631187}], "exons_hg19": [{"cdsend": 25975940, "cdsstart": 25958291, "chr": "17", "position": [[25958213, 25958330], [25965288, 25965380], [25967597, 25967799], [25969263, 25969374], [25972339, 25972375], [25972886, 25972937], [25973572, 25973614], [25974055, 25974144], [25975861, 25976586]], "strand": 1, "transcript": "NM_001330163", "txend": 25976586, "txstart": 25958213}, {"cdsend": 25976008, "cdsstart": 25958291, "chr": "17", "position": [[25958213, 25958330], [25965288, 25965380], [25967597, 25967799], [25969263, 25969374], [25972339, 25972375], [25972886, 25972937], [25973572, 25973614], [25974055, 25974144], [25974295, 25974458], [25975861, 25976586]], "strand": 1, "transcript": "NM_002308", "txend": 25976586, "txstart": 25958213}, {"cdsend": 25976008, "cdsstart": 25958291, "chr": "17", "position": [[25958213, 25958330], [25965288, 25965380], [25967597, 25967799], [25969263, 25969374], [25970550, 25970646], [25972339, 25972375], [25972886, 25972937], [25973572, 25973614], [25974055, 25974144], [25974295, 25974458], [25975861, 25976586]], "strand": 1, "transcript": "NM_009587", "txend": 25976586, "txstart": 25958213}, {"cdsend": 25976586, "cdsstart": 25976586, "chr": "17", "position": [[25958213, 25958330], [25965288, 25965380], [25967668, 25967799], [25969263, 25969374], [25972339, 25972375], [25972886, 25972937], [25973572, 25973614], [25974055, 25974144], [25974295, 25974458], [25975861, 25976586]], "strand": 1, "transcript": "NR_024043", "txend": 25976586, "txstart": 25958213}], "generif": [{"pubmed": 11823532, "text": "ecalectin is a novel eosinophil-activating factor"}, {"pubmed": 12115481, "text": "overexpression of galectin 9 is associated with cell aggregation and apoptosis of melanoma cells"}, {"pubmed": 12223516, "text": "IFN-gamma-induced production of galectin-9 by endothelial cells may play an important role in immune responses by regulating interactions between vascular wall & eosinophils. In situ endothelium from inflammatory diseases expressed galectin-9."}, {"pubmed": 12421975, "text": "Galectin 9 in IFN-gamma-stimulated fibroblasts plays a crucial role as a physiological modulator at inflammatory sites."}, {"pubmed": 12646627, "text": "Gal-9 induces the apoptosis of various immune cells, including activated CD4+ and CD8+ T cells, through the Ca2+-calpain-caspase-1 pathway, playing a role not only in thymocyte maturation but also in immunomodulation by inducing apoptosis of those cells."}, {"pubmed": 12714580, "text": "Changes in the expressions of galectin-9 are potentially important for myeloid cell differentiation into specific lineages."}, {"pubmed": 14758084, "text": "REVIEW: role in a variety of physiological and pathological conditions"}, {"pubmed": 15837748, "text": "Galectin-9 is a possible prognostic factor with antimetastatic potential in breast cancer."}, {"pubmed": 16012760, "text": "Data suggest that galectin-9 is correlated with oral cancer cell-matrix interactions and may therefore play an important role in the metastasis of oral squamous cell carcinomas."}, {"pubmed": 16116184, "text": "Gal-9 plays a role not only in innate immunity but also in acquired immunity by inducing DC maturation and promoting Th1 immune responses."}, {"pubmed": 17069754, "text": "Stimulation of Tim-3 by its ligand galectin-9 results in increased phosphorylation of Y265, suggesting that this tyrosine residue plays an important role in downstream signalling events regulating T-cell fate."}, {"pubmed": 17156439, "text": "Nasopharyngeal carcinoma cells can release HLA class-II positive exosomes containing galectin 9 and/or LMP1."}, {"pubmed": 17167046, "text": "Galectin-9, consisting of two carbohydrate recognition domains (CRDs) induced Jurkat T-cell apoptosis, however, a single CRD had no effect, suggesting the stable dimeric structure of two CRDs is required for the activity."}, {"pubmed": 17446336, "text": "Gal-9 inhibits allergic inflammation of the airway and airway hyperresponsiveness by modulating CD44-dependent leukocyte recognition of the extracellular matrix"}, {"pubmed": 17449641, "text": "TLR3, PI3K, and IRF3 are involved in the poly IC-induced galectin-9 expression in HUVECs"}, {"pubmed": 17596995, "text": "Galectin-9 represents a novel surface marker which might be employed for molecular targeting to the Peyer's patches."}, {"pubmed": 17907924, "text": "These results suggest that galectin-9, but not other galectins, induced proliferation of human osteoblasts through clustering lipid rafts on membrane and subsequent phosphorylation of the c-Src/ERK signaling pathway."}, {"pubmed": 18005988, "text": "Structural analysis of LGALS9 terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue, Lgals9."}, {"pubmed": 18050192, "text": "Gal-9-induced apoptosis of hyperproliferative rheumatoid arthritis fibroblast-like synoviocytes may play a critical role in the suppression of rheumatoid arthritis."}, {"pubmed": 18258591, "text": "Galectin-9 and galectin-1 require different glycan ligands and glycoprotein receptors to trigger T cell death."}, {"pubmed": 18264727, "text": "decreased Gal-9 expression is inversely associated with malignant potential or differentiation of cervical cervical intraepithelial neoplasia and squamous cell carcinoma as a differentiation biomarker."}, {"pubmed": 18401566, "text": "Transient expression of galectin-9L decreased E-selectin levels, while transient expression of galectin-9M or galectin-9S increased E-selectin levels in LoVo cells."}, {"pubmed": 18485114, "text": "increase of TIM-3 expression on PBMCs, overproduction of IFN-gamma in the sera, and increased galectin-9 in PBMCs was observed in acquired aplastic anemia patients"}, {"pubmed": 18977853, "text": "the crystal structure of the human galectin-9 N-terminal carbohydrate recognition domain in complex with N-acetyllactosamine dimers and trimers."}, {"pubmed": 19005181, "text": "Nasopharyngeal carcinoma exosomes induce massive apoptosis in EBV-specific CD4(+) cells used as a model of target T cells. This effect is inhibited by both anti-Tim-3 and antigalectin-9 blocking antibodies."}, {"pubmed": 19100864, "text": "The simultaneous expression of galectin-9 and Tim-3 may indicate an immunoregulatory function, during the ongoing cytotoxic response."}, {"pubmed": 19335620, "text": "Results demonstrate that intracellular galectin-9 transactivates inflammatory cytokine genes in monocytes through direct physical interaction with NF-IL6."}, {"pubmed": 19538882, "text": "Galectin-9 isoforms regulate the E-selectin expression in LoVo cells differently and thus influence the adhesion between LoVo cells and HUVECs in vitro in different modes."}, {"pubmed": 19776007, "text": "Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation"}, {"pubmed": 20206131, "text": "galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway in the absence of bone morphogenetic proteins."}, {"pubmed": 20209097, "text": "galectin-9 production by Kupffer cells links the innate and adaptive immune response in hepatitis C"}, {"pubmed": 20484929, "text": "the Gal-9 level correlated with the eotaxin level in patients with acute eosinophilic pneumonia, but there was no significant correlation between those levels in patients with CEP"}, {"pubmed": 20574007, "text": "Overexpression of the Tim-3 ligand in Gal-9 transgenic mice results in an increase in CD11b-positive Ly-6G-positive myeloid cells and inhibition of immune responses."}, {"pubmed": 21187321, "text": "the effects of galectin-9 on T cells are more complex than previously thought and are mediated by additional receptors apart from Tim-3"}, {"pubmed": 21263071, "text": "TIM-3 and its ligand galectin-9 are constitutively overexpressed in cystic fibrosis (CF) airway epithelial cell surface, an observation further confirmed in CF patient samples; A neutrophil-dominated immune response exists in the CF airways."}, {"pubmed": 21426359, "text": "investigated the source of Gal-9 in the intestine and the mechanism by which Gal-9 modulated DC's phenotyping and sustained the T helper 2 polarization."}, {"pubmed": 21670307, "text": "galectin-9 binding to PDI on T cells potentiates infection with HIV. We identify a mechanism for regulating cell surface redox status via a galectin-glycoprotein lattice, to regulate distinct T-cell functions"}, {"pubmed": 21717191, "text": "data suggest that TIM-3 and its interaction with Gal-9 may play an important role in the pathogenesis of RA and may represent a potential therapeutic target"}, {"pubmed": 22027828, "text": "HDAC3 regulates galectin-9 expression in endothelial cells via interaction with PI3K-IRF3 signal pathway"}, {"pubmed": 22323453, "text": "Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9."}, {"pubmed": 22371007, "text": "Reduced levels of Tim-3 on CD4(pos) CD25(neg) effector cells and of Gal9 in T-regs contribute to impaired immunoregulation in autoimmune hepatitis by rendering effector cells less prone to T-reg control and T-regs less capable of suppressing."}, {"pubmed": 22438246, "text": "Soluble Gal-9 interacts with Tim-3 expressed on the surface of activated CD4(+) T cells. This leads to down-regulation of HIV-1 coreceptors and up-regulation of the cyclin-dependent kinase inhibitor p21."}, {"pubmed": 22505239, "text": "The Tim-3/galectin-9 signaling pathway mediates T-cell senescence in Hepatitis B Virus-associated Hepatocellular Carcinoma."}, {"pubmed": 22650413, "text": "galectin-9 is expressed in majority of samples of normal epithelium, along with regular presence of keratins 14 or 19. This lectin can represent potential marker of normality in cases of studied squamous cell epithelia."}, {"pubmed": 22938412, "text": "galectin-9 suppressed metastasis of hepatocelllular carcinoma cells in multiple steps; propose that galectin-9 might be a new prognostic factor with antimetastatic potential in patients with hepatocellular carcinoma"}, {"pubmed": 23038209, "text": "Plasma levels of Gal-9 may be predictive of a severe inflammation status during the acute phase of HIV-1 infection and could be a potential biomarker during acute infection."}, {"pubmed": 23121677, "text": "macrophages from sputum samples of asthma patients express low levels of galectin-1 and galectin-9, favouring the exacerbated immune response observed in this disease."}, {"pubmed": 23144904, "text": "CD4 T cells expressing Gal-9 on the cell surface (Gal-9(+) Th cells) secrete Gal-9 upon T cell receptor (TCR) stimulation."}, {"pubmed": 23161469, "text": "HCV-infected human hepatocytes express higher levels of Gal-9 and TGF-beta, and upregulate Tim-3 expression."}, {"pubmed": 23180819, "text": "Blocking Gal9 and T cell Ig and mucin domain (Tim)3 interaction in vitro contributes to control of intracellular bacterial replication in human macrophages."}, {"pubmed": 23242525, "text": "These results show a differential regulation of Lgals9 isoform expression during normal and pathological pregnancies and designate Lgals9 as a potential marker for adverse pregnancy outcomes."}, {"pubmed": 23321864, "text": "Expression of Gal-9 in the lung is increased in patients with interstitial pneumonia associated with collagen vascular disease and that Gal-9 may have a protective role against pulmonary fibrosis of these patients."}, {"pubmed": 23339460, "text": "The elevation of serum Gal-9 in the patients with type 2 diabetes is closely linked to GFR and they may be related to the alteration of the immune response and inflammation of the patients with type 2 diabetes and CKD."}, {"pubmed": 23408620, "text": "Galectin-9 impairs the function of NK cells, including cytotoxicity and cytokine production."}, {"pubmed": 23735749, "text": "Data show that galectin-9 induces Treg and Th1 polarization through interaction with antigen-presenting cells."}, {"pubmed": 23818845, "text": "failure of CD4 T cell help during acute HCV is partially due to an imbalance between Th17 and Treg cells whereby exhaustion of both CD4 and CD8 T cells through the Tim-3/Gal-9 pathway"}, {"pubmed": 23866914, "text": "Persistent Gal-9 production might impair Tim-3 activity and contribute to natural killer cell dysfunction in chronic HIV-1 infection."}, {"pubmed": 23936526, "text": "High galectin 9 expression is associated with preeclampsia."}, {"pubmed": 23967307, "text": "a ligand (Gal-9) compartment-dependent regulatory effect on receptor (Tim-3) activities and inflammatory responses via TLR pathways"}, {"pubmed": 24083426, "text": "Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations."}, {"pubmed": 24333696, "text": "Data indicate that endothelial cells expressed five Galectin-9 (LGALS9) splice variants."}, {"pubmed": 24339967, "text": "The results suggest that expression of Gal-9 and Tim-3 in tumor cells may be a potential, independent prognostic factor for patients with gastric cancer. Gal-9 and TIM-3 may play an important part in the gastric carcinogenesis."}, {"pubmed": 24465902, "text": "Galectin-9 reduced survival by inducing apoptosis and suppressed degranulation in HMC-1 cells, while it induced cytokine and chemokine production by these cells by activating ERK1/2."}, {"pubmed": 24477913, "text": "neutrophil TIM-3/Gal-9 signaling is perturbed in the CF airways due to proteolytic degradation of the receptor."}, {"pubmed": 24639110, "text": "Tim-3, which specifically expresses on LSCs, is beneficial for LSCs survival and AML progression by promoting expansion of MDSCs and differentiating into TAMs at the leukemia site"}, {"pubmed": 24651720, "text": "Galectin-9 expressing regulatory T cells, TIM-3+ cytotoxic T cells and NK cells could play an important role in the maintenance of healthy pregnancy."}, {"pubmed": 24695077, "text": "Gal-9 production is induced by influenza virus infection in humans, making it a potential disease biomarker."}, {"pubmed": 24716948, "text": "The expression of E-cadherin in OSCC was significantly lower than the control tissues but galectin-9 expression was conversely higher."}, {"pubmed": 24786365, "text": "Gal-9 as a novel component of the first wave of the cytokine storm in acute HIV infection that is sustained at elevated levels in virally suppressed subjects"}, {"pubmed": 24859692, "text": "Results suggest that galectin-3, -4, -7 and -9 could be involved in the biology of inverted papillomas."}, {"pubmed": 24861051, "text": "We have previously reported on the role of galectin-1 and -9 in endothelial cell function. Here, we review the current knowledge of these two galectins in endothelial cell biology and angiogenesis."}, {"pubmed": 24895689, "text": "two novel genes, galectin 9 and PINCH, were expressed at much higher levels in cancerous lesions than in normal tissues in all the patients with clear-cell carcinoma who were examined"}, {"pubmed": 24919464, "text": "Results strongly suggest that Gal-9 is involved in tumorigenesis of gastric cancer."}, {"pubmed": 24958847, "text": "action of agonist anti-4-1BB in suppressing autoimmune and allergic inflammation was completely dependent on Galectin-9 (Gal-9). Gal-9 directly bound to 4-1BB, in a site distinct from the binding site of antibodies and the natural ligand of 4-1BB"}, {"pubmed": 24976296, "text": "PPARG inhibits cell invasion, migration and epithelial-mesenchymal transition through upregulation of galectin-9 in vitro and in vivo."}, {"pubmed": 25008927, "text": "Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferon."}, {"pubmed": 25091272, "text": "Tim-3/Gal-9 interaction favors apoptosis of MBP-specific T lymphocytes in benign multiple sclerosis; this process is reduced in PPMS by the up-regulation of Bat3"}, {"pubmed": 25135732, "text": "It was suggested that the overexpression of Tim-3/Gal-9 pathway may be related to the pathogenesis of RSA."}, {"pubmed": 25259711, "text": "current study confirms the prognostic value of galectin-1 and identifies galectin-9Delta5 as novel potential prognostic markers in early stage NSCLC."}, {"pubmed": 25578313, "text": "The Gal-9/Tim-3 signal is important for the regulation of decidua NK cells function, which is beneficial for the maintenance of a normal pregnancy."}, {"pubmed": 25716202, "text": "Gal-9 expression is a potential independent prognostic factor for OS and RFS in patients with clear-cell renal cell carcinoma"}, {"pubmed": 25754930, "text": "Data show that dengue virus (DV) infection specifically increased mRNA and protein levels of galectin-9 (Gal-9)."}, {"pubmed": 25784621, "text": "Participation of TIM-3 and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo"}, {"pubmed": 25823465, "text": "Results show that galectin-9 inhibited the growth of hepatocellular carcinoma (HCC) cells by apoptosis, but not cell cycle arrest. Its antitumor effect is mediated by miR1246."}, {"pubmed": 25880730, "text": "Galectin-9 is involved in the pathogenesis of autoimmune thyroid disease.Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells."}, {"pubmed": 25947381, "text": "T cell receptor (TCR)-CD3 complex and the Lck kinase were required for Ca(2+) mobilization but not for apoptosis induction in Jurkat cells."}, {"pubmed": 25956455, "text": "the increased expression may be helpful to differentiate of oral squamous cell carcinoma from oral leukoplakia and oral lichen planus"}, {"pubmed": 26086204, "text": "LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux"}, {"pubmed": 26239720, "text": "Study found that LGALS9 was expressed in 68.4% of the human gastrointestinal stromal tumors (GIST) and Tim-3 in the infiltrated NK cells of 68.4% of GISTs and suggest that Tim-3/LGALS9 pathway may be involved in the immune checkpoint mechanism of GISTs."}, {"pubmed": 26239725, "text": "We also observed that the Gal-9/miR-22 axis may influence lymphocyte apoptosis and tumor cell proliferation. These studies contribute to a further understanding of the microRNAmediated regulation of the Gal-9 pathway ."}, {"pubmed": 26260906, "text": "These findings suggest that Gal-9 can be a candidate of therapeutic target in the treatment of cholangiocarcinoma"}, {"pubmed": 26279267, "text": "TIM-3 and its ligand, galectin-9 (Gal-9), constitute an autocrine loop critical for leukemic stem cells self-renewal and development of human acute myeloid leukemia."}, {"pubmed": 26342682, "text": "an abnormal Tim-3/Gal-9 pathway was able to facilitate the development of preeclampsia."}, {"pubmed": 26475932, "text": "may contribute to elevated galectin-9 and adaptive immune inhibition in hepatitis C virus infection"}, {"pubmed": 26582205, "text": "These results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of monoclonal IgE to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction."}, {"pubmed": 26598225, "text": "In a genetic analysis of heavy consumers of alcohol, the authors associated 2 single-nucleotide polymorphisms in LGALS9 with the development of advanced alcoholic liver disease."}, {"pubmed": 26663989, "text": "Gal-9 suppressed T-helper 17 (Th17) and expanded regulatory T cells (Tregs), resulting in decreased IL-17 production and increased secretion of TGF-beta1"}, {"pubmed": 26797414, "text": "Gal-9 suppresses the growth of GBC, possibly by inducing apoptosis and altering miRNA expression"}, {"pubmed": 26823850, "text": "The expression of Galectin-9 mRNA has a close relationship with pathological differentiation, tumor staging, and recurrence metastasis in hepatocellular carcinoma"}, {"pubmed": 26891020, "text": "The integrative analysis of galectins(Gal-1, -3, -4, -9) discriminated IBD from other intestinal inflammatory conditions and could be used as potential mucosal biomarker."}, {"pubmed": 27028892, "text": "Galectin-9 stimulated migration in human NK-92 cells by affecting F-actin polarization through the Rho/ROCK1 signaling pathway."}, {"pubmed": 27240351, "text": "Results showed that in acute febrile phase, galectin-9 and galectin-3BP were induced in dengue patients compared to healthy controls suggesting that both molecules might be important inflammatory mediators in acute dengue virus infection."}, {"pubmed": 27253379, "text": "Our data suggest a role of galectin-9 in regulating HIV transcription and viral production in vivo during therapy"}, {"pubmed": 27394439, "text": "this study shows that the levels of expression of Gal-9 on CD4+ T cells, CD8+ T cells, CD56+ T cells and in serum in patients with systemic lupus erythematosus are significantly higher than those of healthy controls"}, {"pubmed": 27581941, "text": "In this review, we summarize the latest knowledge on the structure, receptors, cellular targets, trafficking pathways and functional properties of galectin-9 and discuss how galectin-9-mediated signalling cascades can be exploited in cancers and immunotherapies"}, {"pubmed": 27799141, "text": "We investigated tumor-infiltrating CD4 and CD8 T cells and the expression of PD-L1, Galectin-9, and XAGE1 in stage I to IIIA lung adenocarcinomas using a tissue microarray to deduce their contribution to overall survival, and our data showed that PD-L1 expression was a positive indicator, whereas Galectin-9 and XAGE1 expression was negative."}, {"pubmed": 28045432, "text": "The human recombinant galectin-9 has demonstrated anti-cancer activities, including inducing apoptosis in hematological, dermatological and gastrointestinal malignancies. In this review, the molecular characteristics, history and apoptosis-inducing potential of galectin-9 are described. [review]"}, {"pubmed": 28103502, "text": "this study shows that in osteosarcoma patients, Tim3 expression did not directly mediate immune suppression, but the interaction between Tim3+ T cells and monocytes, naive CD4+ T cells, and Gal9-expressing CD4+ CD25+ Tregs could resulting in progressive suppression of Th1 responses"}, {"pubmed": 28112232, "text": "In conclusion, these findings suggest that the serum levels of Gal-1, Gal-3, and Gal-9 may be associated with large artery atherosclerotic stroke."}, {"pubmed": 28321034, "text": "These findings may indicate that an increase in the Gal-9 level, a novel immune checkpoint molecule, can reflect immune-related adverse effects of various biotherapies."}, {"pubmed": 28393295, "text": "results suggested that Tim-3 and Gal-9 could downregulate T cell inflammation in Osteoarthritis"}, {"pubmed": 28394331, "text": "Galectin 9 is a novel dectin 1 ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1-galectin 9 axis, CD4(+) and CD8(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity."}, {"pubmed": 28466780, "text": "these data suggest that the high Tim-3 expression in monocytes could be utilized by tumor-promoting Gal-9 expression on CD4(+) T cells"}, {"pubmed": 28470686, "text": "Low Gal-9 expression is associated with pancreatic and ampullary cancer."}, {"pubmed": 28554765, "text": "the present study was the first to report the participation of Gal-9 in Chagas disease"}, {"pubmed": 28656219, "text": "Our data reveal that Gal9 suppresses the growth of liver metastasis, possibly by inducing apoptosis through a mechanism involving mitochondria and changes in miRNA expression. Thus, Gal9 might serve as a therapeutic agent for the treatment of liver metastasis from pancreatic cancer."}, {"pubmed": 28687490, "text": "X-ray structure of a protease-resistant mutant form of human galectin-9 having two carbohydrate recognition domains with a metal-binding site has been presented."}, {"pubmed": 28750861, "text": "Results show that human acute myeloid leukemia (AML) cells possess a secretory pathway which leads to the production and release of soluble Tim-3 and galectin-9. Both proteins prevent the activation of NK cells and impair their AML cell-killing activity."}, {"pubmed": 28756232, "text": "Tim3/Gal-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kappaB signaling pathway."}, {"pubmed": 28772217, "text": "The interaction between Gal-9/TIM-3 pathway and follicular helper cells contributed to viral persistent in chronic hepatitis C virus infection."}, {"pubmed": 28810662, "text": "Galectin-9, a soluble lectin expressed by T cells, endothelial cells and dendritic cells, binds to and retains PDI on the cell surface."}, {"pubmed": 28889122, "text": "these data indicate a novel role for galectin-9 in modulating innate immunity by inducing aldehyde dehydrogenase activity in CD103+ dendritic cells"}, {"pubmed": 28939284, "text": "Gal-9 was down modulated in stroma of patients with chronic gastritis and Helicobacter pylori infection."}, {"pubmed": 29027155, "text": "T-cell immunoglobulin mucin-3/galectin-9 (Tim-3/Gal-9) binding signaling can also engage other binding partners to induce distinct cellular responses [Review]."}, {"pubmed": 29127350, "text": "galectin-9 could expand mTregs through galectin-9/Tim-3 interaction. In conclusion, increased mTregs are found only in inflammatory phase of chronic HBV infection. Galectin-9, associated with liver inflammation, contributes to the expansion of mTregs through galectin-9/Tim-3 interaction."}, {"pubmed": 29202955, "text": "Significantly elevated Gal-9 levels were found in both minimal-mild (I-II) and moderate-severe (III-IV) stages of endometriosis in comparison with healthy controls."}, {"pubmed": 29205636, "text": "this study showed that blood level of galectin-9 increased during pregnancy"}, {"pubmed": 29310109, "text": "Gal-9 is a promising biomarker for allograft dysfunction, but unable to differentiate allograft rejection from other causes of renal dysfunction in kidney transplantation recipients"}, {"pubmed": 29316949, "text": "These findings indicated that EZH2 facilitates galectin-9 expression by epigenetically repressing miR-22 and that galectin-9, which is known as an immunosuppressant, also functions as a tumor suppressor in HCC."}, {"pubmed": 29361803, "text": "Gal-9 expression determined the DFS and OS of ovarian cancer patients in two opposing ways-moderate Gal-9 expression was correlated with a reduced outcome as compared to Gal-9 negative cases, while patients with high Gal-9 expression showed the best outcome."}, {"pubmed": 29389859, "text": "Studies indicate tumor-derived galectin-1, galectin-3 and galectin-9 in various cancers and anticancer therapies that target these molecules [Review]."}, {"pubmed": 29433546, "text": "Data suggest a role for galectin-9 (Gal-9) in angiogenesis, joint inflammation, and possibly other inflammatory diseases."}, {"pubmed": 29452091, "text": "Exosomal total protein, Tim-3 and Galectin-9 were up-regulated in non-small cell lung cancer plasma."}, {"pubmed": 29500586, "text": "the effects of different galectin-9 isoforms in endothelial cell biology depend on the cellular activation status."}, {"pubmed": 29732570, "text": "Galectin-9 binds to CD206 on M2 macrophages, which appear to drive angiogenesis and the production of chemokines that support melanoma growth."}, {"pubmed": 29978574, "text": "Gal-9 presented a critical role in the development of iTreg cells"}, {"pubmed": 30106451, "text": "High GAL9 expression is associated with gastric cancer."}, {"pubmed": 30120234, "text": "Gal-9 intrinsically regulates B cell activation and may differentially modulate B cell receptor signaling at steady state and within germinal centers."}, {"pubmed": 30150656, "text": "endogenous Gal9 is protective against apoptosis and enhances synovial fibroblast viability suggesting that its role in RA is both pathogenic and pro-inflammatory"}, {"pubmed": 30223894, "text": "Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9."}, {"pubmed": 30291028, "text": "Data show that IgD interacts with basophils through the CD44-binding protein galectin-9."}, {"pubmed": 30383222, "text": "results suggest that atypical ubiquitination and accumulation of ubiquitinated proteins in lysosomes play a pivotal role in galectin-9-induced non-apoptotic death in PC-3 cells."}, {"pubmed": 30599005, "text": "these results suggest that galectin-9 may be involved in the pathogenesis of systemic sclerosis"}, {"pubmed": 31019124, "text": "Our results showed that serum Gal-3 and Gal-9 should not be considered biomarkers of inflammatory bowel disease. Despite not being a specific marker for Crohn's Disease, serum Gal-3BP might be used as an adjuvant biomarker for disease activity."}, {"pubmed": 31168974, "text": "exosome-derived galectin-9 may have a role in rejection and poor prognosis after liver transplantation"}, {"pubmed": 31197461, "text": "In specimens from skull base chordoma patients MiR-455-5p was identified as a regulator of Gal9 expression. Immunopositivity for Gal9 was associated with tumor invasion, Karnofsky performance status score, and total tumor-infiltrating lymphocytes count; downregulation of miR-455-5p was correlated with tumor invasion and poor prognosis."}, {"pubmed": 31291985, "text": "Our results suggest that targeting the Gal9/Tim-3 axis could be effective in combination with induction chemotherapy to increase the likelihood of complete remission in AML patients."}, {"pubmed": 31337623, "text": "sorting nexin SNX3 is transported with Rab5a vesicles and that its PX domain enables vesicle-phagosome contact by binding to PI(3)P in the phagosomal coat. Moreover, the C-terminal region of SNX3 recruits galectin-9, a lectin implicated in protein and membrane recycling, which we identify as a further regulator of phagosome compaction."}, {"pubmed": 31337865, "text": "Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels."}, {"pubmed": 31354733, "text": "The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer."}, {"pubmed": 31401383, "text": "Our results indicate that higher levels of post treatment day 30 Tim-3 and Gal-9 were novel and potentially useful predictors for infection occurred within 12months after kidney transplantation."}, {"pubmed": 31430907, "text": "This study identifies for the first time an immunomodulatory protein, Gal-9, that triggers activation of granulocytes leading to increased PAD-4 expression and generation of citrullinated autoantigens. This pathway may represent a potentially important mechanism for development of Rheumatoid Arthritis."}, {"pubmed": 31454748, "text": "Patients with low galectin-9 level on tumor cells or high galectin-9 level on TILs were more likely to have poor prognosis."}, {"pubmed": 31464928, "text": "Results find that serum levels of galectin-9 were significantly higher in patients with autoimmune hepatitis (AIH).  Steroid treatment of AIH patients significantly reduced serum galectin-9 levels suggesting that LGALS9 could be a novel marker for AIH."}, {"pubmed": 31470166, "text": "Our results highlight the pivotal role of GAL-9 in regulation of immune suppressive features of gliomas"}, {"pubmed": 31487707, "text": "Both Galectin-1 and -9 were associated with the occurrence of endometrial carcinoma and its pathological behavior and lymph node metastasis. High expression of Galectin-1 suggests a poor prognosis, whereas high expression of Galectin-9 was associated with early pathological changes."}, {"pubmed": 31600237, "text": "To investigate associations between the SNPs of the GAL-9 gene (LGALS9) and serum levels in rheumatoid arthritis patients...The AG genotype of LGALS9 (rs3763959) has been associated with a higher presence of bone erosion in Rheumatoid arthritis (RA) patients."}, {"pubmed": 31609000, "text": "Molecular and clinical characterization of Galectin-9 in glioma through 1,027 samples."}, {"pubmed": 31732662, "text": "The data demonstrated significant upregulation of Gal-9 on NK cells in HIV-infected groups versus healthy controls. Gal-9 expression was associated with impaired expression of cytotoxic effector molecules granzyme B, perforin, and granulysin."}, {"pubmed": 31747929, "text": "Seven of the eight LGALS9 CpG sites correlated significantly with LGALS9 mRNA levels in patients with myeloma. Methylation at five CpG sites showed a strong inverse correlation and at two sites a weak positive correlation. High LGALS9 mRNA expression was significantly associated with increased overall survival of myeloma patients."}, {"pubmed": 31907020, "text": "A novel IFNalpha-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma."}, {"pubmed": 31995728, "text": "In response to damage, Gal9 displaces USP9X from complexes with TAK1 and promotes K63 ubiquitination of TAK1 thus activating AMPK on damaged lysosomes and triggering autophagy."}, {"pubmed": 32055023, "text": "Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels."}, {"pubmed": 32205423, "text": "Galectin-9 and VISTA Expression Define Terminally Exhausted T Cells in HIV-1 Infection."}, {"pubmed": 32231038, "text": "Different Expression Pattern of TIM-3 and Galectin-9 Molecules by Peripheral and Peritoneal Lymphocytes in Women with and without Endometriosis."}, {"pubmed": 32319832, "text": "Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis."}, {"pubmed": 32345786, "text": "Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis."}, {"pubmed": 32424467, "text": "Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma."}, {"pubmed": 32565125, "text": "Increased serum levels of galectin-9 in patients with chikungunya fever."}, {"pubmed": 32678033, "text": "Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings."}, {"pubmed": 32771893, "text": "Characterisation of endogenous Galectin-1 and -9 expression in monocyte and macrophage subsets under resting and inflammatory conditions."}, {"pubmed": 32862376, "text": "Down-regulation and Clinical Implication of Galectin-9 Levels in Patients with Acute Coronary Syndrome and Chronic Kidney Disease."}, {"pubmed": 32889240, "text": "Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation."}, {"pubmed": 32902187, "text": "Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells."}, {"pubmed": 33062039, "text": "Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer."}, {"pubmed": 33082168, "text": "Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer."}, {"pubmed": 33093453, "text": "Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity."}, {"pubmed": 33107565, "text": "Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts."}, {"pubmed": 33112295, "text": "Galectin-9 regulates HTR8/SVneo function via JNK signaling."}, {"pubmed": 33123595, "text": "Circulating T Cells Exhibit Different TIM3/Galectin-9 Expression in Patients with Obesity and Obesity-Related Diabetes."}, {"pubmed": 33143141, "text": "Plasma Levels of a Cleaved Form of Galectin-9 Are the Most Sensitive Biomarkers of Acquired Immune Deficiency Syndrome and Tuberculosis Coinfection."}, {"pubmed": 33227818, "text": "Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL."}, {"pubmed": 33285511, "text": "Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways."}, {"pubmed": 33310773, "text": "Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors."}, {"pubmed": 33316546, "text": "Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis."}, {"pubmed": 33329552, "text": "Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity."}, {"pubmed": 33547304, "text": "Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy."}, {"pubmed": 33559190, "text": "The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma."}, {"pubmed": 33606034, "text": "Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid."}, {"pubmed": 33692448, "text": "Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis."}, {"pubmed": 33923930, "text": "The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes."}, {"pubmed": 34067072, "text": "High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia."}, {"pubmed": 34090287, "text": "THE ROLE OF GALECTIN-9 IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C AND ITS CONNECTION WITH THE TYPE OF THERAPY, THE DEGREE OF FIBROSIS, CLINICAL, LABORATORY, AUTOIMMUNE AND INTEGRATIVE INDICATORS."}, {"pubmed": 34137463, "text": "Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia."}, {"pubmed": 34290225, "text": "Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-kappaB pathway in HNSCC."}, {"pubmed": 34371260, "text": "Gene polymorphisms of LGALS2, LGALS3 and LGALS9 in patients with rheumatoid arthritis."}, {"pubmed": 34411088, "text": "Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection."}, {"pubmed": 34543981, "text": "Functional role of galectin-9 in directing human innate immune reactions to Gram-negative bacteria and T cell apoptosis."}, {"pubmed": 34581822, "text": "Transcriptional regulation of LGALS9 by HAND2 and FOXO1 in human endometrial stromal cells in women with regular cycles."}, {"pubmed": 34847625, "text": "Galectin-9 mediates neutrophil capture and adhesion in a CD44 and beta2 integrin-dependent manner."}, {"pubmed": 34931005, "text": "Chemokines modulate glycan binding and the immunoregulatory activity of galectins."}, {"pubmed": 35087074, "text": "Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins."}, {"pubmed": 35202002, "text": "Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma."}, {"pubmed": 35216164, "text": "Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome."}, {"pubmed": 35377045, "text": "Galectin-8 and -9 as prognostic factors for cervical cancer."}, {"pubmed": 35874664, "text": "Natural Killer Cells Induce CD8(+) T Cell Dysfunction via Galectin-9/TIM-3 in Chronic Hepatitis B Virus Infection."}, {"pubmed": 35967337, "text": "Galectin-9 contributes to the pathogenesis of atopic dermatitis via T cell immunoglobulin mucin-3."}, {"pubmed": 36527024, "text": "Galectin-9 expression clinically associated with mature dendritic cells infiltration and T cell immune response in colorectal cancer."}, {"pubmed": 36599470, "text": "T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins."}, {"pubmed": 36622166, "text": "Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells."}, {"pubmed": 36672263, "text": "Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naive Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts."}, {"pubmed": 36768365, "text": "The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis."}, {"pubmed": 36835000, "text": "Plasma N-Cleaved Galectin-9 Is a Surrogate Marker for Determining the Severity of COVID-19 and Monitoring the Therapeutic Effects of Tocilizumab."}, {"pubmed": 37127426, "text": "Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells."}, {"pubmed": 37352334, "text": "Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens."}, {"pubmed": 37566493, "text": "Expression and Clinical Significance of Peripheral Blood IL-17A, IL-22, Tim-3, and gal-9 in Children with Infectious Mononucleosis."}, {"pubmed": 37627231, "text": "Galectin-9 as a Potential Modulator of Lymphocyte Adhesion to Endothelium via Binding to Blood Group H Glycan."}, {"pubmed": 37793539, "text": "Expression of Tim-3/Galectin-9 pathway and CD8+T cells and related factors in patients with cystic echinococcosis."}, {"pubmed": 37813965, "text": "The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity."}, {"pubmed": 37905655, "text": "Evaluation of the Relationship Between miRNA-22-3p and Gal-9 Levels in Glioblastoma."}, {"pubmed": 37946029, "text": "CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia."}, {"pubmed": 38022614, "text": "TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines."}, {"pubmed": 38071058, "text": "[Significance of Tim-3 and Its Ligand Galectin-9 in Th1/Th2 Imbalance in Patients with Multiple Myeloma]."}, {"pubmed": 38108336, "text": "Activated Tim-3/Galectin-9 participated in the development of multiple myeloma by negatively regulating CD4 T cells."}, {"pubmed": 38141929, "text": "Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-alpha-induced activation of fibroblast-like synoviocytes."}, {"pubmed": 38267906, "text": "TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1."}, {"pubmed": 38369502, "text": "Diffuse large B-cell lymphoma: the significance of CD8[+] tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway."}, {"pubmed": 38528665, "text": "The Dual Role of the NFATc2/galectin-9 Axis in Modulating Tumor-Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma."}, {"pubmed": 38608008, "text": "Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV."}, {"pubmed": 38815863, "text": "ATXN3 functions as a tumor suppressor through potentiating galectin-9-mediated apoptosis in human colon adenocarcinoma."}, {"pubmed": 38972269, "text": "The expression of TIM-3 and Gal-9 on macrophages and Hofbauer cells in the placenta of preeclampsia patients."}, {"pubmed": 39000016, "text": "Expression of Intracellular Galectin-8 and -9 in Endometrial Cancer."}], "genomic_pos": {"chr": "17", "end": 27649560, "ensemblgene": "ENSG00000168961", "start": 27629798, "strand": 1}, "genomic_pos_hg19": {"chr": "17", "end": 25976586, "start": 25956824, "strand": 1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0002519", "pubmed": 25578313, "qualifier": "involved_in", "term": "natural killer cell tolerance induction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006935", "qualifier": "involved_in", "term": "chemotaxis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006954", "pubmed": 23817958, "qualifier": "involved_in", "term": "inflammatory response"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007565", "pubmed": 23242525, "qualifier": "involved_in", "term": "female pregnancy"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0010628", "qualifier": "involved_in", "term": "positive regulation of gene expression"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010628", "pubmed": 16116184, "qualifier": "involved_in", "term": "positive regulation of gene expression"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010629", "pubmed": 23408620, "qualifier": "involved_in", "term": "negative regulation of gene expression"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010629", "pubmed": 25578313, "qualifier": "involved_in", "term": "negative regulation of gene expression"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032496", "pubmed": 25578313, "qualifier": "involved_in", "term": "response to lipopolysaccharide"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032673", "pubmed": 16116184, "qualifier": "NOT involved_in", "term": "regulation of interleukin-4 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032674", "pubmed": 16116184, "qualifier": "NOT involved_in", "term": "regulation of interleukin-5 production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032682", "pubmed": 25754930, "qualifier": "involved_in", "term": "negative regulation of chemokine production"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0032689", "qualifier": "involved_in", "term": "negative regulation of type II interferon production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032689", "pubmed": 23408620, "qualifier": "involved_in", "term": "negative regulation of type II interferon production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032720", "pubmed": 25578313, "qualifier": "involved_in", "term": "negative regulation of tumor necrosis factor production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032729", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of type II interferon production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032731", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of interleukin-1 beta production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032733", "pubmed": [16116184, 20209097], "qualifier": "involved_in", "term": "positive regulation of interleukin-10 production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032735", "pubmed": [16116184, 25754930], "qualifier": "involved_in", "term": "positive regulation of interleukin-12 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032736", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of interleukin-13 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032753", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of interleukin-4 production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032753", "pubmed": 25578313, "qualifier": "involved_in", "term": "positive regulation of interleukin-4 production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032755", "pubmed": 24465902, "qualifier": "involved_in", "term": "positive regulation of interleukin-6 production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032757", "pubmed": 24465902, "qualifier": "involved_in", "term": "positive regulation of interleukin-8 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032760", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of tumor necrosis factor production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032834", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034134", "pubmed": 16116184, "qualifier": "NOT involved_in", "term": "toll-like receptor 2 signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034142", "pubmed": 16116184, "qualifier": "NOT involved_in", "term": "toll-like receptor 4 signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0038066", "pubmed": 16116184, "qualifier": "involved_in", "term": "p38MAPK cascade"}, {"evidence": "HMP", "gocategory": "BP", "id": "GO:0043123", "pubmed": 12761501, "qualifier": "involved_in", "term": "positive regulation of canonical NF-kappaB signal transduction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043305", "pubmed": 24465902, "qualifier": "involved_in", "term": "negative regulation of mast cell degranulation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045953", "pubmed": 23408620, "qualifier": "involved_in", "term": "negative regulation of natural killer cell mediated cytotoxicity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046007", "pubmed": 23817958, "qualifier": "involved_in", "term": "negative regulation of activated T cell proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046598", "pubmed": 21670307, "qualifier": "involved_in", "term": "positive regulation of viral entry into host cell"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051092", "pubmed": 25754930, "qualifier": "involved_in", "term": "positive regulation of NF-kappaB transcription factor activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060135", "pubmed": 25578313, "qualifier": "involved_in", "term": "maternal process involved in female pregnancy"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070241", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of activated T cell autonomous cell death"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070371", "pubmed": 16116184, "qualifier": "involved_in", "term": "ERK1 and ERK2 cascade"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0070374", "pubmed": [24465902, 25754930], "qualifier": "involved_in", "term": "positive regulation of ERK1 and ERK2 cascade"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070555", "pubmed": 23817958, "qualifier": "involved_in", "term": "response to interleukin-1"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071346", "pubmed": 23817958, "qualifier": "involved_in", "term": "cellular response to type II interferon"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071636", "pubmed": 20209097, "qualifier": "involved_in", "term": "positive regulation of transforming growth factor beta production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0071639", "pubmed": 24465902, "qualifier": "involved_in", "term": "positive regulation of monocyte chemotactic protein-1 production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0097029", "pubmed": 25754930, "qualifier": "NOT involved_in", "term": "mature conventional dendritic cell differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0098586", "pubmed": 25754930, "qualifier": "involved_in", "term": "cellular response to virus"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1900744", "pubmed": 24465902, "qualifier": "NOT involved_in", "term": "regulation of p38MAPK cascade"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1901224", "pubmed": 25754930, "qualifier": "involved_in", "term": "positive regulation of non-canonical NF-kappaB signal transduction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2000510", "pubmed": 25754930, "qualifier": "involved_in", "term": "positive regulation of dendritic cell chemotaxis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:2000562", "qualifier": "involved_in", "term": "negative regulation of CD4-positive, alpha-beta T cell proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000562", "pubmed": 20209097, "qualifier": "involved_in", "term": "negative regulation of CD4-positive, alpha-beta T cell proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000563", "pubmed": 16116184, "qualifier": "involved_in", "term": "positive regulation of CD4-positive, alpha-beta T cell proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000670", "pubmed": 16116184, "qualifier": "involved_in", "term": "positive regulation of dendritic cell apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2001190", "pubmed": 16116184, "qualifier": "involved_in", "term": "positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2001200", "pubmed": 16116184, "qualifier": "involved_in", "term": "positive regulation of dendritic cell differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2001269", "pubmed": 24465902, "qualifier": "involved_in", "term": "positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 20209097, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 23242525, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 23242525, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0062023", "pubmed": 25037231, "qualifier": "located_in", "term": "collagen-containing extracellular matrix"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0005534", "pubmed": 9045665, "qualifier": "enables", "term": "galactose binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016936", "qualifier": "enables", "term": "galactoside binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019899", "pubmed": 21670307, "qualifier": "enables", "term": "enzyme binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0030246", "qualifier": "enables", "term": "carbohydrate binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0030246", "pubmed": 18977853, "qualifier": "enables", "term": "carbohydrate binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0048030", "pubmed": 16116184, "qualifier": "enables", "term": "disaccharide binding"}]}, "homologene": {"genes": [[7955, 327284], [7955, 337597], [7955, 556717], [7955, 100124603], [7955, 100148547], [9544, 100427967], [9598, 454519], [9606, 3965], [9615, 442861], [9913, 510813]], "id": 32078}, "interpro": [{"desc": "Galectin, carbohydrate recognition domain", "id": "IPR001079", "short_desc": "Galectin_CRD"}, {"desc": "Concanavalin A-like lectin/glucanase domain superfamily", "id": "IPR013320", "short_desc": "ConA-like_dom_sf"}, {"desc": "Galectin-like", "id": "IPR044156", "short_desc": "Galectin-like"}], "ipi": ["IPI00010477", "IPI00163684", "IPI00293267", "IPI00789269", "IPI00908681"], "map_location": "17q11.2", "name": "galectin 9", "other_names": ["ecalectin", "gal-9", "galectin-9", "lectin, galactoside-binding, soluble, 9", "tumor antigen HOM-HD-21", "urate transporter/channel protein"], "pantherdb": {"HGNC": "6570", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "109496", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 10090, "uniprot_kb": "O08573"}, {"RGD": "3004", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 10116, "uniprot_kb": "P47967"}, {"RGD": "3005", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 10116, "uniprot_kb": "P97840"}, {"ZFIN": "ZDB-GENE-131119-90", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7955, "uniprot_kb": "E9QFW3"}, {"ZFIN": "ZDB-GENE-030131-9543", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7955, "uniprot_kb": "F1QX26"}, {"ZFIN": "ZDB-GENE-060312-19", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7955, "uniprot_kb": "Q29RA0"}, {"ZFIN": "ZDB-GENE-070822-22", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7955, "uniprot_kb": "F1QWY9"}, {"ZFIN": "ZDB-GENE-040718-159", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7955, "uniprot_kb": "Q7T119"}, {"WormBase": "WBGene00008284", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q18813"}, {"WormBase": "WBGene00002269", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q9N384"}, {"WormBase": "WBGene00002265", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q20684"}, {"WormBase": "WBGene00009833", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q20549"}, {"WormBase": "WBGene00002272", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "G5EC10"}, {"WormBase": "WBGene00002273", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "G5EBV4"}, {"WormBase": "WBGene00206478", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "F5GU58"}, {"WormBase": "WBGene00002270", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q09605"}, {"WormBase": "WBGene00002271", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q09610"}, {"WormBase": "WBGene00002274", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q94215"}, {"WormBase": "WBGene00017080", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q5ZR27"}, {"WormBase": "WBGene00002268", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "G5EFI4"}, {"WormBase": "WBGene00018649", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q9GZE0"}, {"WormBase": "WBGene00009748", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "O01331"}, {"WormBase": "WBGene00009747", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "O01330"}, {"WormBase": "WBGene00009751", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "C4RVF6"}, {"WormBase": "WBGene00018651", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q9GZD8"}, {"WormBase": "WBGene00007768", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "K8ERT0"}, {"WormBase": "WBGene00009746", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "O01329"}, {"WormBase": "WBGene00235368", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "U4PM93"}, {"WormBase": "WBGene00018650", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q9GZD9"}, {"WormBase": "WBGene00002267", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q18625"}, {"WormBase": "WBGene00004165", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q9U2I7"}, {"WormBase": "WBGene00018254", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q20256"}, {"WormBase": "WBGene00018255", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q09277"}, {"WormBase": "WBGene00002266", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "Q09581"}, {"WormBase": "WBGene00002264", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 6239, "uniprot_kb": "P36573"}, {"FlyBase": "FBgn0031214", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7227, "uniprot_kb": "Q9VPI7"}, {"FlyBase": "FBgn0031213", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7227, "uniprot_kb": "Q9VPI6"}, {"FlyBase": "FBgn0034365", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7227, "uniprot_kb": "A1ZBB1"}, {"FlyBase": "FBgn0038419", "ortholog_type": "O", "panther_family": "PTHR11346", "taxid": 7227, "uniprot_kb": "Q9VEW5"}], "uniprot_kb": "O00182"}, "pathway": {"reactome": [{"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-451927", "name": "Interleukin-2 family signaling"}], "wikipathways": {"id": "WP2877", "name": "Vitamin D Receptor Pathway"}}, "pdb": ["2EAK", "2EAL", "2YY1", "2ZHK", "2ZHL", "2ZHM", "2ZHN", "3LSD", "3LSE", "3NV1", "3NV2", "3NV3", "3NV4", "3WLU", "3WV6"], "pfam": "PF00337", "pharmgkb": "PA30347", "pharos": {"target_id": 13101, "tdl": "Tchem"}, "prosite": "PS51304", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF176720", "relationship": "is"}, {"id": "GNF198532", "relationship": "is"}, {"id": "GNF209438", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF030878", "relationship": "is"}, {"id": "GNF050148", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF274136", "relationship": "is"}, {"id": "GNF275171", "relationship": "is"}, {"id": "GNF275173", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": [{"id": "GNF337868", "relationship": "is"}, {"id": "GNF338231", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000017.11", "NC_060941.1"], "protein": ["NP_001317092.1", "NP_002299.2", "NP_033665.1", "XP_006721955.1", "XP_006721956.1", "XP_006721958.1", "XP_011523098.1", "XP_054172020.1", "XP_054172021.1", "XP_054172022.1", "XP_054172023.1"], "rna": ["NM_001330163.2", "NM_002308.4", "NM_009587.3", "NR_024043.2", "XM_006721892.4", "XM_006721893.4", "XM_006721895.5", "XM_011524796.3", "XM_054316045.1", "XM_054316046.1", "XM_054316047.1", "XM_054316048.1"], "translation": [{"protein": "NP_001317092.1", "rna": "NM_001330163.2"}, {"protein": "XP_006721956.1", "rna": "XM_006721893.4"}, {"protein": "NP_033665.1", "rna": "NM_009587.3"}, {"protein": "XP_054172020.1", "rna": "XM_054316045.1"}, {"protein": "XP_054172021.1", "rna": "XM_054316046.1"}, {"protein": "XP_054172023.1", "rna": "XM_054316048.1"}, {"protein": "XP_006721958.1", "rna": "XM_006721895.5"}, {"protein": "NP_002299.2", "rna": "NM_002308.4"}, {"protein": "XP_011523098.1", "rna": "XM_011524796.3"}, {"protein": "XP_054172022.1", "rna": "XM_054316047.1"}, {"protein": "XP_006721955.1", "rna": "XM_006721892.4"}]}, "reporter": {"HG-U133_Plus_2": "203236_s_at", "HG-U95Av2": ["38091_at", "766_at"], "HTA-2_0": ["TC17000312.hg.1", "TC17002136.hg.1"], "HuEx-1_0": ["3713397", "3715274", "3749206"], "HuGene-1_1": ["8005458", "8005809", "8013450"], "HuGene-2_1": ["17121622", "17121624"]}, "retired": [90793, 113376, 116410, 147124], "summary": "The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008].", "symbol": "LGALS9", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1416836"}, "unigene": "Hs.81337", "uniprot": {"Swiss-Prot": "O00182", "TrEMBL": ["K7EPS0", "J3QKK6", "J3KS82", "J3QS92", "J3KSA0"]}, "wikipedia": {"url_stub": "LGALS9"}}